223 related articles for article (PubMed ID: 22763379)
41. Comprehensive molecular analysis of mismatch repair gene defects in suspected Lynch syndrome (hereditary nonpolyposis colorectal cancer) cases.
Mueller J; Gazzoli I; Bandipalliam P; Garber JE; Syngal S; Kolodner RD
Cancer Res; 2009 Sep; 69(17):7053-61. PubMed ID: 19690142
[TBL] [Abstract][Full Text] [Related]
42. Selection of patients with germline MLH1 mutated Lynch syndrome by determination of MLH1 methylation and BRAF mutation.
Bouzourene H; Hutter P; Losi L; Martin P; Benhattar J
Fam Cancer; 2010 Jun; 9(2):167-72. PubMed ID: 19949877
[TBL] [Abstract][Full Text] [Related]
43. Gene conversion is a frequent mechanism of inactivation of the wild-type allele in cancers from MLH1/MSH2 deletion carriers.
Zhang J; Lindroos A; Ollila S; Russell A; Marra G; Mueller H; Peltomaki P; Plasilova M; Heinimann K
Cancer Res; 2006 Jan; 66(2):659-64. PubMed ID: 16423994
[TBL] [Abstract][Full Text] [Related]
44. Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome.
Berginc G; Bracko M; Ravnik-Glavac M; Glavac D
Fam Cancer; 2009; 8(4):421-9. PubMed ID: 19526325
[TBL] [Abstract][Full Text] [Related]
45. Lynch syndrome associated with two MLH1 promoter variants and allelic imbalance of MLH1 expression.
Hesson LB; Packham D; Kwok CT; Nunez AC; Ng B; Schmidt C; Fields M; Wong JW; Sloane MA; Ward RL
Hum Mutat; 2015 Jun; 36(6):622-30. PubMed ID: 25762362
[TBL] [Abstract][Full Text] [Related]
46. Epitope-positive truncating MLH1 mutation and loss of PMS2: implications for IHC-directed genetic testing for Lynch syndrome.
Zighelboim I; Powell MA; Babb SA; Whelan AJ; Schmidt AP; Clendenning M; Senter L; Thibodeau SN; de la Chapelle A; Goodfellow PJ
Fam Cancer; 2009; 8(4):501-4. PubMed ID: 19672700
[TBL] [Abstract][Full Text] [Related]
47. Implication of DNA repair genes in Lynch-like syndrome.
Xicola RM; Clark JR; Carroll T; Alvikas J; Marwaha P; Regan MR; Lopez-Giraldez F; Choi J; Emmadi R; Alagiozian-Angelova V; Kupfer SS; Ellis NA; Llor X
Fam Cancer; 2019 Jul; 18(3):331-342. PubMed ID: 30989425
[TBL] [Abstract][Full Text] [Related]
48. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.
Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ
Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668
[TBL] [Abstract][Full Text] [Related]
49. Epigenetic mechanisms in the pathogenesis of Lynch syndrome.
Peltomäki P
Clin Genet; 2014 May; 85(5):403-12. PubMed ID: 24443998
[TBL] [Abstract][Full Text] [Related]
50. Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification.
Parsons MT; Buchanan DD; Thompson B; Young JP; Spurdle AB
J Med Genet; 2012 Mar; 49(3):151-7. PubMed ID: 22368298
[TBL] [Abstract][Full Text] [Related]
51. Utility of p16 immunohistochemistry for the identification of Lynch syndrome.
Payá A; Alenda C; Pérez-Carbonell L; Rojas E; Soto JL; Guillén C; Castillejo A; Barberá VM; Carrato A; Castells A; Llor X; Andreu M; Koh J; Enders GH; Benlloch S; Jover R
Clin Cancer Res; 2009 May; 15(9):3156-62. PubMed ID: 19383812
[TBL] [Abstract][Full Text] [Related]
52. Germline epimutation in humans.
Cropley JE; Martin DI; Suter CM
Pharmacogenomics; 2008 Dec; 9(12):1861-8. PubMed ID: 19072644
[TBL] [Abstract][Full Text] [Related]
53. Diagnosis of Constitutional Mismatch Repair-Deficiency Syndrome Based on Microsatellite Instability and Lymphocyte Tolerance to Methylating Agents.
Bodo S; Colas C; Buhard O; Collura A; Tinat J; Lavoine N; Guilloux A; Chalastanis A; Lafitte P; Coulet F; Buisine MP; Ilencikova D; Ruiz-Ponte C; Kinzel M; Grandjouan S; Brems H; Lejeune S; Blanché H; Wang Q; Caron O; Cabaret O; Svrcek M; Vidaud D; Parfait B; Verloes A; Knappe UJ; Soubrier F; Mortemousque I; Leis A; Auclair-Perrossier J; Frébourg T; Fléjou JF; Entz-Werle N; Leclerc J; Malka D; Cohen-Haguenauer O; Goldberg Y; Gerdes AM; Fedhila F; Mathieu-Dramard M; Hamelin R; Wafaa B; Gauthier-Villars M; Bourdeaut F; Sheridan E; Vasen H; Brugières L; Wimmer K; Muleris M; Duval A;
Gastroenterology; 2015 Oct; 149(4):1017-29.e3. PubMed ID: 26116798
[TBL] [Abstract][Full Text] [Related]
54. [Expression and clinical significance of MMR protein and MLH1 promoter methylation testing in endometrial cancer].
Jin W; Wang LQ; Liu Y; Liu AJ
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):823-830. PubMed ID: 30585020
[No Abstract] [Full Text] [Related]
55. Germline epimutation: A basis for epigenetic disease in humans.
Martin DI; Ward R; Suter CM
Ann N Y Acad Sci; 2005; 1054():68-77. PubMed ID: 16339653
[TBL] [Abstract][Full Text] [Related]
56. Germline epimutation of MLH1 in individuals with multiple cancers.
Suter CM; Martin DI; Ward RL
Nat Genet; 2004 May; 36(5):497-501. PubMed ID: 15064764
[TBL] [Abstract][Full Text] [Related]
57. A novel germline MLH1 mutation causing Lynch Syndrome in patients from the Republic of Macedonia.
Hiljadnikova-Bajro M; Josifovski T; Panovski M; Dimovski AJ
Croat Med J; 2012 Oct; 53(5):496-501. PubMed ID: 23100212
[TBL] [Abstract][Full Text] [Related]
58. Germline promoter hypermethylation of tumor suppressor genes in gastric cancer.
Wu PY; Zhang Z; Wang JM; Guo WW; Xiao N; He Q; Wang YP; Fan YM
World J Gastroenterol; 2012 Jan; 18(1):70-8. PubMed ID: 22228973
[TBL] [Abstract][Full Text] [Related]
59. Detailed characterization of MLH1 p.D41H and p.N710D variants coexisting in a Lynch syndrome family with conserved MLH1 expression tumors.
Pineda M; González-Acosta M; Thompson BA; Sánchez R; Gómez C; Martínez-López J; Perea J; Caldés T; Rodríguez Y; Landolfi S; Balmaña J; Lázaro C; Robles L; Capellá G; Rueda D
Clin Genet; 2015 Jun; 87(6):543-8. PubMed ID: 25060679
[TBL] [Abstract][Full Text] [Related]
60. Detection of DNA mismatch repair proteins in fresh human blood lymphocytes--towards a novel method for hereditary non-polyposis colorectal cancer (Lynch syndrome) screening.
Hassen S; Boman BM; Ali N; Parker M; Somerman C; Ali-Khan Catts ZJ; Ali AA; Fields JZ
J Exp Clin Cancer Res; 2011 Oct; 30(1):100. PubMed ID: 22017758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
